Halozyme Therapeutics | HALO - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 3.86B 1.28B 2026-03
Baxter International USD 309M 756M 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cytokinetics USD -169.32M 19.48M 2026-03
DBV Technologies USD -45.9M 12.42M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
MannKind USD 2.93M 5.98M 2026-03
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Pfizer USD 6.01B 18M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
United Therapeutics USD 355M 11.1M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12